These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis? Gravito-Soares M; Gravito-Soares E; Gomes D; Tome L Ann Hepatol; 2019; 18(1):78-88. PubMed ID: 31113613 [TBL] [Abstract][Full Text] [Related]
6. Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy. Reynolds TM; Mewies C; Hamilton J; Wierzbicki AS; J Clin Pathol; 2018 Jul; 71(7):608-613. PubMed ID: 29358478 [TBL] [Abstract][Full Text] [Related]
7. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171 [TBL] [Abstract][Full Text] [Related]
8. Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease. Baratta F; Pastori D; Tozzi G; D'Erasmo L; Di Costanzo A; Arca M; Ettorre E; Ginanni Corradini S; Violi F; Angelico F; Del Ben M Liver Int; 2019 Dec; 39(12):2301-2308. PubMed ID: 31392821 [TBL] [Abstract][Full Text] [Related]
9. Could lysosomal acid lipase enzyme activity be used for clinical follow-up in cryptogenic cirrhosis? Köse E; Çağatay E; Yaraş T; Kısa PT; Güler S; Gülten ZA; Akarsu M; Oktay Y; Kayalı HA; Arslan N Turk J Med Sci; 2022 Aug; 52(4):1075-1084. PubMed ID: 36326406 [TBL] [Abstract][Full Text] [Related]
11. Lysosomal Acid Lipase Deficiency Leading to Liver Cirrhosis: a Case Report of a Rare Variant Mutation. Cunha-Silva M; Mazo DFC; Corrêa BR; Lopes TM; Arrelaro RC; Ferreira GL; Rabello MI; Sevá-Pereira T; Escanhoela CAF; Almeida JRS Ann Hepatol; 2019; 18(1):230-235. PubMed ID: 31113597 [TBL] [Abstract][Full Text] [Related]
12. Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Lukacs Z; Barr M; Hamilton J Clin Chim Acta; 2017 Aug; 471():201-205. PubMed ID: 28532785 [TBL] [Abstract][Full Text] [Related]
13. Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency. Santillán-Hernández Y; Almanza-Miranda E; Xin WW; Goss K; Vera-Loaiza A; Gorráez-de la Mora MT; Piña-Aguilar RE World J Gastroenterol; 2015 Jan; 21(3):1001-8. PubMed ID: 25624737 [TBL] [Abstract][Full Text] [Related]
14. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Hamilton J; Jones I; Srivastava R; Galloway P Clin Chim Acta; 2012 Aug; 413(15-16):1207-10. PubMed ID: 22483793 [TBL] [Abstract][Full Text] [Related]
15. A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease. Dairaku T; Iwamoto T; Nishimura M; Endo M; Ohashi T; Eto Y Mol Genet Metab; 2014 Feb; 111(2):193-6. PubMed ID: 24295952 [TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants. Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270 [TBL] [Abstract][Full Text] [Related]
17. Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease. Shteyer E; Villenchik R; Mahamid M; Nator N; Safadi R Int J Mol Sci; 2016 Feb; 17(3):312. PubMed ID: 26927097 [TBL] [Abstract][Full Text] [Related]
18. Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease. Polimeni L; Pastori D; Baratta F; Tozzi G; Novo M; Vicinanza R; Troisi G; Pannitteri G; Ceci F; Scardella L; Violi F; Angelico F; Del Ben M Intern Emerg Med; 2017 Dec; 12(8):1159-1165. PubMed ID: 28900817 [TBL] [Abstract][Full Text] [Related]
19. Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease? Baratta F; Pastori D; Polimeni L; Tozzi G; Violi F; Angelico F; Del Ben M Int J Mol Sci; 2015 Nov; 16(12):28014-21. PubMed ID: 26602919 [TBL] [Abstract][Full Text] [Related]
20. Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis. Reynolds T J Clin Pathol; 2013 Nov; 66(11):918-23. PubMed ID: 23999269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]